Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ

Watchlist Manager
Eckert & Ziegler Strahlen und Medizintechnik AG Logo
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Watchlist
Price: 44.04 EUR 2.32% Market Closed
Market Cap: 918m EUR
Have any thoughts about
Eckert & Ziegler Strahlen und Medizintechnik AG?
Write Note

Eckert & Ziegler Strahlen und Medizintechnik AG
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Eckert & Ziegler Strahlen und Medizintechnik AG
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Accounts Payable
€6m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
3%
Carl Zeiss Meditec AG
XETRA:AFX
Accounts Payable
€186.7m
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
16%
Stratec SE
XETRA:SBS
Accounts Payable
€13.1m
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
8%
Siemens Healthineers AG
XETRA:SHL
Accounts Payable
€2B
CAGR 3-Years
0%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
Accounts Payable
€198.9m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
3%
Sartorius AG
XETRA:SRT
Accounts Payable
€226.3m
CAGR 3-Years
-22%
CAGR 5-Years
1%
CAGR 10-Years
11%
No Stocks Found

Eckert & Ziegler Strahlen und Medizintechnik AG
Glance View

Market Cap
918m EUR
Industry
Health Care

Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. The company is headquartered in Berlin, Berlin and currently employs 866 full-time employees. The company went IPO on 2008-02-25. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

EUZ Intrinsic Value
57.08 EUR
Undervaluation 23%
Intrinsic Value
Price

See Also

What is Eckert & Ziegler Strahlen und Medizintechnik AG's Accounts Payable?
Accounts Payable
6m EUR

Based on the financial report for Sep 30, 2024, Eckert & Ziegler Strahlen und Medizintechnik AG's Accounts Payable amounts to 6m EUR.

What is Eckert & Ziegler Strahlen und Medizintechnik AG's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
3%

Over the last year, the Accounts Payable growth was 23%. The average annual Accounts Payable growth rates for Eckert & Ziegler Strahlen und Medizintechnik AG have been 13% over the past three years , 12% over the past five years , and 3% over the past ten years .

Back to Top